Alejandro Segura-Tudela

5PUBLICATIONS
76CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 30, 2025
The Rise of Fine-Tuned CAR-Based Therapies Against Acute Myeloid Leukemia.

Alejandro Segura Tudela, Ron Geller, Bruno Paiva

|Feb 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas

|Oct 20, 2023
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2.

Rodrigo Lázaro-Gorines, Patricia Pérez, Ignacio Heras-Murillo

|Apr 28, 2023
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response.

Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean L Harwood

|Apr 01, 2022
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.

Belén Blanco, Ángel Ramírez-Fernández, Clara Bueno

Pageof 1